Schedule 13G ownership disclosure

NeuBase Therapeutics, Inc.

Security class unavailable · CUSIP: 64132K102

Event date: 2019-07-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,019,055
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-005253
Form type
SC 13G
Filer
NeuBase Therapeutics, Inc.
CIK
CIK 1173281
Filed
Jul 22, 2019
Reporting period
Jul 12, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub